Home › Colorectal Cancer › Ohio › Columbus
Pag-aaral pangklinika para sa Colorectal Cancer sa Columbus, OH
24 pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Columbus (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Nagre-recruitPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- at 8 pa
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Nagre-recruitPhase 1
- ALX Center 10, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
- The Ohio State University Comprehensive Cancer Center, Columbus
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Nagre-recruitPhase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Nagre-recruitPhase 2/3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Nagre-recruitPhase 2
- Research Site, Columbus
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
- Ohio Health, Columbus
- Zangmeister Center, Columbus
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Nagre-recruitPhase 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Nagre-recruitPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Nagre-recruitPhase 4
- Zangmeister Cancer Center, Columbus
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Nagre-recruitPhase 1
- Ohio State University, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Memorial Hospital, Marysville · 27 mi ang layo
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Nagre-recruitObservasyonal na pag-aaral
- The Mark H Zangmeister Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Nagre-recruitObservasyonal na pag-aaral
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Pag-aaral para sa Colorectal Cancer sa ibang lungsod
- Houston, TX102 pag-aaral
- New York City, NY78 pag-aaral
- Nashville, TN69 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA59 pag-aaral
- Arlington, VA52 pag-aaral
- St. Louis, MO50 pag-aaral
- San Antonio, TX46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Chicago, IL34 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer57 pag-aaral
- Kanser sa Suso40 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Kanser sa Baga37 pag-aaral
- Acute Myeloid Leukemia35 pag-aaral
- Chronic Lymphocytic Leukemia28 pag-aaral
- Metastatic Cancer27 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Kanser sa Prostate24 pag-aaral
- Multiple Myeloma24 pag-aaral
- Melanoma21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.